A Discussion on Protocol Amendments and Clinical Study Reports in Affected Ongoing Trials.
 Trouble viewing this email? Read it online
Follow us on:       
Sponsored by Grand River
Magazine  I  News  I  Research  I  Directory  I  Topics  I  Classifieds  I  Resources  I  Provider Microsites
Sponsored by Renaissance cdmo

EXPERT'S OPINION
FDA Response to COVID-19
A Discussion on Protocol Amendments and Clinical Study Reports in Affected Ongoing Trials.
Read More >>

BREAKING NEWS
AbbVie, I-Mab Enter Global Immuno-Oncology Alliance
AbbVie to pay as much as $1.74 billion for Lemzoparlimab, one of I-Mab's leading drug candidates for the treatment of multiple cancers.
Read More >>

Having Formulation Challenges?
Adare, the leader is taste-masking, utilizes the coacervation process to solve your formulation challenges from bitter tasting API’s to accelerating your development timelines.
Learn More >>


CNS Achieves Key Milestones in Berubicin Dual-track Mfg. Strategy
CNS and Pii complete successful lab simulation of the lyophilization cycle and Pii is expected to begin manufacturing Berubicin during 3Q20.
Read More >>

Catalent Invests $50M at Bloomington Facility
To install an additional high-speed vial filling line to support growing pipeline of clinical programs and commercial launches at the site.
Read More >>

Uhlmann Bottling Systems: IBC Family of Products
IBC family of products provide industry leading OEE as high as 95% with a space saving monoblock design.
Learn More >>

Gilead Sciences Signs Agreement with Jounce Therapeutics
Licenses Jounce’s JTX-1811, a monoclonal antibody targeting tumor-infiltrating T regulatory cells.
Read More >>

Stevanato Group, Nelson Labs Sign E&L Testing Pact
Partnership will provide Extractables and Leachables testing at SG US Technology Excellence Center in Boston.
Read More >>

World-Class Oncology Manufacturing
With over 60 years of oncology experience, BioPharma Solutions’ Halle, Germany facility is uniquely designed to deliver high-quality products with optimum efficiency and speed to market.
Learn More >>


Seqens Opens New HPAPI Unit
Will produce highly active ingredients at its Villeneuve-La-Garenne site.
Read More >>

PPD, Lupus Therapeutics to Support Lupus Clinical Research
To provide enhanced protocol and trial optimization capabilities for its customers leveraging LT’s scientific, operational and drug development expertise.
Read More >>

How to Control and Modify the Release of Today’s Insoluble, Potent APIs
Synchronizing and controlling API delivery, extrusion-spheronization is a robust technique offering pharmaceutical companies a reliable way to manufacture.
Learn More >>


Alcami, Trevana Enter Manufacturing Pact
Alcami to provide commercial manufacturing for recently FDA approved OLINVYK.
Read More >>

   
WEBINAR SPOTLIGHT

 
IDF
Faster & Better, Your Success to IND & BLA Through S-CHOice Cell Line & 2-Step Purification Platform
September 15 | 2:00 PM EDT
Expediting development timeline is directly related to obtaining IND clearance and starting phase 1 study faster.

WHITEPAPER SPOTLIGHT

 
meet-iqvia
Manufacturing Sterile Products White Paper
Released by: Lubrizol Life Science Health
In this white paper, Lubrizol Life Science Health reviews sterile pharmaceutical products, aseptic processing, methods of product sterilization and more.

UPCOMING WEBINAR SERIES

Feature Story Image September 23rd:
Maintaining Critical Drug Supply During the Pandemic
Sponsored by:
RESERVE YOUR SEAT   →
Feature Story Image September 30th:
FDA Regulations and Inspections Amid COVID-19
Sponsored by:
RESERVE YOUR SEAT   →


We hope you enjoyed this edition of Contract Pharma Direct's Friday Week in Review.

You are receiving this message because you opted in at contractpharma.com. To change your preferences or unsubscribe please use the links below.

To ensure delivery and proper display of your emails, please add our email address (cp@email.contractpharma.com) to your address book and if needed enable images in your email client.

To update your user profile please click here.

To unsubscribe or change your email subscription preferences please click here.

If you are having trouble with receiving Contract Pharma Magazine or would like to receive it, click here.

Advertise with us

Our mailing address is:

Contract Pharma
Rodman Media
25 Philips Parkway, Ste 200
Montvale, NJ 07645
Tel: 201-825-2552

© Copyright 2020 Contract Pharma All rights reserved.